| Sep 24, 12 | Shire and Smith & Nephew in demand as investors seek defensive stocks | | No data |
| Sep 14, 12 | Mining shares push FTSE 100 to six month high after Fed's latest attempt to boost economy | | No data |
| Sep 14, 12 | Mining shares fill top ten FTSE risers as market surges on US Federal Reserve QE3 moves | | No data |
| Sep 7, 12 | Mining shares boosted by ECB and China hopes, while Xstrata jumps on Glencore move | | No data |
| Aug 7, 12 | Do sports drinks and hydration theory hold any water? | | No data |
| Jul 26, 12 | GlaxoSmithKline chief apologises after company fined for mis-selling | | No data |
| Jul 25, 12 | Arm adds 8% despite Apple disappointment while FTSE flatlines | | No data |
| Jul 16, 12 | GlaxoSmithKline pays $3bn for lupus drug partner | | No data |
| Jul 16, 12 | London 2012: GlaxoSmithKline launches anti-doping ads | | No data |
| Jul 16, 12 | Marlon Devonish in Olympics anti-drugs advert - video | | No data |
| Jul 13, 12 | GlaxoSmithKline rises on US and Europe drug submission, amid renewed talk of interest in Biomarin | | No data |
| Jul 8, 12 | Pharma overtakes arms industry to top the league of misbehaviour | | No data |
| Jul 8, 12 | Portfolio challenge: Barclays teaches school investors a painful lesson | | No data |
| Jul 5, 12 | GlaxoSmithKline: former chairman denies knowledge of $3bn US deal | | No data |
| Jul 4, 12 | GlaxoSmithKline's bribes are evidence that Big Pharma isn't working | | No data |
| Jul 3, 12 | GlaxoSmithKline fined $3bn after bribing doctors to increase drugs sales | | No data |
| Jul 2, 12 | FTSE finishes higher despite disappointing data, while Soco surges on Vietnam deal | | No data |
| Jul 2, 12 | GlaxoSmithKline pays $3bn to settle US investigation into its marketing practices | | No data |
| Jun 29, 12 | EU summit deal lifts FTSE nearly 1.5% but Vodafone suffers on competition concerns | | No data |
| Jun 28, 12 | GlaxoSmithKline dips on renewed talk of interest in US group BioMarin | | No data |
| Jun 28, 12 | AstraZeneca in demand as long term seller turns positive at Glaxo's expense | | No data |
| Jun 8, 12 | GlaxoSmithKline extends tender offer for Human Genome Sciences | | No data |
| May 24, 12 | GlaxoSmithKline and AstraZeneca invest in antibiotic research | | No data |
| May 11, 12 | Marks & Spencer leads FTSE higher but investors still nervous after Spain, Greece, China and JP Morgan | | No data |
| May 10, 12 | GlaxoSmithKline turns up the heat on Human Genome Sciences | | No data |
| May 9, 12 | GlaxoSmithKline steps up hostile bid for Human Genome Sciences | | No data |
| May 9, 12 | GlaxoSmithKline launches hostile $2.6bn bid for US group Human Genome | | No data |
| May 4, 12 | Shareholder rebels with a cause | | No data |
| Apr 30, 12 | Man Group leads FTSE lower | | No data |
| Apr 27, 12 | Man jumps on broker upgrades and continuing bid talk, as FTSE finishes week on positive note | | No data |